News
- 2025.05.16
- 株主通信「SymBio VISION vol.27」(Japanese only)
- 2025.05.12
- SymBio Confirms Brincidofovir (BCV) Efficacy Against Malignant Brain Tumors and Identification of Biomarker Genes (Predictive Factors of Efficacy)
- 2025.05.08
- Summary of Consolidated Financial Statements for the First Three Months of Fiscal Year Ending December 31, 2025 [Japanese GAAP]
- 2025.04.21
- Notice regarding the Issuance of Stock Acquisition Rights(Stock Options) to the Company’s Directors
- 2025.04.21
- Notice regarding the Issuance of Stock Acquisition Rights (Stock Options) to the Company’s Employees
Selection News
- 2025.05.16
- 株主通信「SymBio VISION vol.27」(Japanese only)
- 2025.03.28
- 「動画で観るシンバイオ製薬」を更新しました。(Japanese only)
- 2025.03.28
- 第20期定時株主総会の動画を掲載しました。(Japanese only)
- 2025.02.26
- 2024年12月期決算説明会の動画を掲載しました。(Japanese only)
- 2025.02.13
- 決算説明会資料（2024年12月期）(Japanese only)
- 2024.08.13
- Article on 2024 1H Earnings Call Featured in Nikkei Biotech Online (Japanese only)
Source: Nikkei Biotech ONLINE, 2024.08.07
Although Nikkei BP grants permission to use the articles, the content of the articles does not constitute a recommendation to purchase/invest in a specific company/organization or product/service.
Unauthorized reproduction, duplication, or electronic storage of the articles/photos/charts, etc. is prohibited.
- 2023.11.17
- Notice of Relocation of Head Office